You just read:

Terumo BCT's Spectra Optia® Apheresis System Is the First and Only Device on the European Market Indicated to Treat Guillain-Barré Syndrome and Myasthenia Gravis using Therapeutic Plasma Exchange

News provided by

Terumo BCT

06 Apr, 2017, 08:00 BST